asedebart   Click here for help

GtoPdb Ligand ID: 14670

Synonyms: Lu AG13909 | Lu-AG13909
Compound class: Antibody
Comment: Asedebart (Lu AG13909) is a humanized monoclonal antibody that binds (neutralizes) human ACTH (corticotropin) by acting as a ligand trap. Peptide matches for the heavy and light chains of asedebart are claimed in patent US10047157B2, and form the antibody named Ab13.H therein [1]. The antibody is intended to block ACTH-mediated activation of melanocortin receptors in the adrenal glands, as a mechanism to reduce the overproduction of cortisol and aldosterone in ACTH‑dependent conditions such as Cushing's disease/syndrome.
No information available.
Summary of Clinical Use Click here for help
Asedebart (Lu AG13909) was progressed as a clinical candidate for the treatment of conditions that are characterised by elevated cortisol levels, such as Cushing's disease and congenital adrenal hyperplasia [2]. Asedebart has been granted orphan designations for use in these indications in Japan, the US.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05669950 A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia Phase 1/Phase 2 Interventional H. Lundbeck A/S
NCT06471829 A Trial of Lu AG13909 in Adult Participants With Cushing's Disease Phase 2 Interventional H. Lundbeck A/S